V-Mart Retail launches 4 new stores
V-Mart Retail launches 4 new stores

V-Mart Retail launches 4 new stores

DSIJ Intelligence Article rating: 3.2

With the new outlets, total number of V-Mart Retail stores has increased to 243 stores in 186 cities across 19 states. 

Domestic MF AUM declines by 4 per cent.
Domestic MF AUM declines by 4 per cent.

Domestic MF AUM declines by 4 per cent.

DSIJ Intelligence Article rating: 5.0

The latest data by industry body, Association of Mutual Funds in India (AMFI) shows that asset under management (AUM) of the domestic mutual fund has declined by 3.8% month on month basis.

Polycab India opens its second Experience Centre
Polycab India opens its second Experience Centre

Polycab India opens its second Experience Centre

DSIJ Intelligence Article rating: 3.5

Polycab India Limited on Wednesday announced that the company has inaugurated Polycab Experience Centre at Shop No. 1, Sakharam Apartment, old Tapkir Galli, Pune.

Religare Enterprises to conduct postal ballot for disinvestment
Religare Enterprises to conduct postal ballot for disinvestment

Religare Enterprises to conduct postal ballot for disinvestment

DSIJ Intelligence Article rating: 5.0

Last week, Religare Enterprises announced that the company will conduct postal ballot to obtain approval of the shareholders of the company by the way of special resolution on disinvestment of entire investment of the company in material subsidiaries and Religare Housing Development Finance Corporation Limited and Sales, disposal and leasing of assets exceeding 20 per cent of assets of Religare Finvest Limited.

Understanding the game of needs and wants
Understanding the game of needs and wants

Understanding the game of needs and wants

DSIJ Intelligence Article rating: 5.0

Usually, people use the words “need” and “want” interchangeably. However, they are way different from each other. Read on to find out more.

Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets
Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets

Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets

Apurva Joshi Article rating: 5.0

Zydus Cadila has received the final approval from the United States Federation of Drug Authority (USFDA) to market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

DSIJ Intelligence Article rating: 5.0

The markets on October 09, 2019 opened gap up. BSE Sensex is trading at 37,991.57, up by 459.59 points and the Nifty is closed at 11,256.80, up by 130.40 points.

RSS
First32523253325432553257325932603261Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR